Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

3rd Jan 2024 09:23

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

Stifel cuts Burberry to 'hold' (buy) - price target 1,550 (1,950) pence

----------

UBS cuts Burberry price target to 1,380 (1,525) pence - 'sell'

----------

Citigroup raises Experian price target to 3,122 (2,893) pence - 'neutral'

----------

UBS cuts Entain price target to 1,355 (1,420) pence - 'buy'

----------

Bernstein raises Whitbread price target to 3,600 (3,214) pence - 'market-perform'

----------

Bernstein raises InterContinental Hotels target to 6,900 (5,766) pence - 'market-perf.'

----------

Barclays raises Spirax-Sarco target to 10,580 (9,870) pence - 'equal weight'

----------

RBC cuts Rentokil initial price target to 575 (610) pence - 'outperform'

----------

Jefferies cuts AstraZeneca to 'hold' (buy) - price target 11,000 (12,500) pence

----------

Jefferies raises GSK to 'buy' (hold) - price target 1,900 (1,550) pence

----------

FTSE 250

----------

Barclays cuts Bodycote plc price target to 650 (750) pence - 'equal weight'

----------

Barclays starts Premier Foods with 'equal weight' - price target 140 pence

----------

Barclays starts Cranswick with 'overweight' - price target 4,580 pence

----------

SMALL CAP AND OTHER COMPANIES

----------

Morgan Stanley raises Deliveroo price target to 150 (140) pence - 'overweight'

----------

Barclays starts Greencore with 'equal weight' - price target 110 pence

----------

Evercore ISI cuts Ryanair to 'in-line' (outperform)

----------

Copyright 2024 Alliance News Ltd. All Rights Reserved.

FTSE 100 Latest
Value7,706.28
Change21.79